TY - JOUR
T1 - Emerging approaches for imaging vulnerable plaques in patients
AU - Choi, Seung Hyuk
AU - Chae, Andrew
AU - Chen, Cheng Han
AU - Merki, Esther
AU - Shaw, Peter X.
AU - Tsimikas, Sotirios
PY - 2007/2/1
Y1 - 2007/2/1
N2 - The diagnosis of vulnerable plaques, which have the propensity to develop atherothrombosis, remains an elusive goal in clinical medicine. The most accepted features of vulnerable plaques, such as a large lipid core, increased inflammatory milieu and thin fibrous caps, have been well characterized through pathological studies. The ability to image a vulnerable plaque in susceptible patients would theoretically result in useful prognostic information that can be used to either monitor or treat patients at risk more aggressively. Several invasive techniques, such as integrated backscatter, virtual histology, palpography, optical coherence tomography and thermal heterogeneity, have been validated ex vivo and are now being evaluated in clinical studies. Non-invasive techniques, such as nuclear imaging, show promise in identifying increased metabolic activity and characteristic features of vulnerable plaques in patients. Natural history and intervention studies will need to be performed to determine whether identifying and treating vulnerable plaques will lead to improved clinical outcomes.
AB - The diagnosis of vulnerable plaques, which have the propensity to develop atherothrombosis, remains an elusive goal in clinical medicine. The most accepted features of vulnerable plaques, such as a large lipid core, increased inflammatory milieu and thin fibrous caps, have been well characterized through pathological studies. The ability to image a vulnerable plaque in susceptible patients would theoretically result in useful prognostic information that can be used to either monitor or treat patients at risk more aggressively. Several invasive techniques, such as integrated backscatter, virtual histology, palpography, optical coherence tomography and thermal heterogeneity, have been validated ex vivo and are now being evaluated in clinical studies. Non-invasive techniques, such as nuclear imaging, show promise in identifying increased metabolic activity and characteristic features of vulnerable plaques in patients. Natural history and intervention studies will need to be performed to determine whether identifying and treating vulnerable plaques will lead to improved clinical outcomes.
UR - http://www.scopus.com/inward/record.url?scp=33846856184&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33846856184&partnerID=8YFLogxK
U2 - 10.1016/j.copbio.2007.01.001
DO - 10.1016/j.copbio.2007.01.001
M3 - Review article
C2 - 17234398
AN - SCOPUS:33846856184
SN - 0958-1669
VL - 18
SP - 73
EP - 82
JO - Current Opinion in Biotechnology
JF - Current Opinion in Biotechnology
IS - 1
ER -